×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
WVE – wave life sciences ltd. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
WVE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/28
08:13 pm
wve
Promising Genomics & Synthetic Biology Stocks to Consider in 2025 [Yahoo! Finance]
Medium
Report
Promising Genomics & Synthetic Biology Stocks to Consider in 2025 [Yahoo! Finance]
3/26
12:10 pm
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Low
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
3/26
07:42 am
wve
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531 [Yahoo! Finance]
Low
Report
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531 [Yahoo! Finance]
3/26
07:30 am
wve
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531
Medium
Report
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531
3/8
02:05 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/5
08:11 am
wve
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Medium
Report
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
3/5
02:17 am
wve
WAVE Life Sciences Ltd (WVE) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Clinical ... [Yahoo! Finance]
Medium
Report
WAVE Life Sciences Ltd (WVE) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Clinical ... [Yahoo! Finance]
3/4
08:05 am
wve
Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
3/4/2025
07:30 am
WVE
wave life sciences ltd. - ordinary shares
BEAT
Report
13.4%
wave life sciences ltd. - ordinary shares
3/4/2025
07:30 am
WVE
wave life sciences ltd. - ordinary shares
BEAT
Report
9.3%
wave life sciences ltd. - ordinary shares
3/4/2025
07:30 am
WVE
wave life sciences ltd. - ordinary shares
BEAT
Report
8.1%
wave life sciences ltd. - ordinary shares
3/4/2025
07:30 am
WVE
wave life sciences ltd. - ordinary shares
BEAT
Report
7.0%
wave life sciences ltd. - ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/26
07:38 am
wve
Form 8-K Wave Life Sciences Ltd. For: Mar 26
Low
Report
Form 8-K Wave Life Sciences Ltd. For: Mar 26
3/21
09:00 pm
wve
Form 4 Wave Life Sciences Ltd. For: Mar 20 Filed by: HENRY CHRISTIAN O
Low
Report
Form 4 Wave Life Sciences Ltd. For: Mar 20 Filed by: HENRY CHRISTIAN O
3/20
04:04 pm
wve
Form 144 Wave Life Sciences Ltd. Filed by: HENRY CHRISTIAN O
Low
Report
Form 144 Wave Life Sciences Ltd. Filed by: HENRY CHRISTIAN O
3/7
09:05 pm
wve
Form 4 Wave Life Sciences Ltd. For: Mar 07 Filed by: BOLNO PAUL
Medium
Report
Form 4 Wave Life Sciences Ltd. For: Mar 07 Filed by: BOLNO PAUL
3/7
09:00 pm
wve
Form 4 Wave Life Sciences Ltd. For: Mar 05 Filed by: Verdine Gregory L.
Medium
Report
Form 4 Wave Life Sciences Ltd. For: Mar 05 Filed by: Verdine Gregory L.
3/7
05:10 pm
wve
Form 144 Wave Life Sciences Ltd. Filed by: BOLNO PAUL
Medium
Report
Form 144 Wave Life Sciences Ltd. Filed by: BOLNO PAUL
3/5
05:14 pm
wve
Form 4 Wave Life Sciences Ltd. For: Mar 04 Filed by: Vargeese Chandra
Medium
Report
Form 4 Wave Life Sciences Ltd. For: Mar 04 Filed by: Vargeese Chandra
3/4
08:00 am
wve
Form 10-K Wave Life Sciences Ltd. For: Dec 31
Medium
Report
Form 10-K Wave Life Sciences Ltd. For: Dec 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
9/16
Wave Life Sciences Announces Fast Track Designation from U.S. FDA for Suvodirsen
14.5%
3/2 Form POS AM Wave Life Sciences Ltd. 10.1%
10/26 Wave Life Sciences Ltd (NASDAQ: WVE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 7.7%
2/13 Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 7.4%
4/24 Wave Life Sciences to return $7.2 mln PPP loan [Reuters] 7.4%
3/3 Edited Transcript of WVE earnings conference call or presentation 2-Mar-20 1:00pm GMT [Yahoo! Finance News] 6.7%
8/29 Wave Life Sciences Ltd (NASDAQ: WVE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 6.7%
7/29 Wave Life Sciences Reports Second Quarter 2019 Financial Results and Provides Business Update 5.7%
10/19 Wave Life Sciences Ltd (NASDAQ: WVE) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.1%
5/24 Wave Life Sciences Ltd (NASDAQ: WVE) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 5.0%
3/2 Form POS AM Wave Life Sciences Ltd. 10.1%
10/26 Wave Life Sciences Ltd (NASDAQ: WVE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 7.7%
2/13 Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 7.4%
4/24 Wave Life Sciences to return $7.2 mln PPP loan [Reuters] 7.4%
3/3 Edited Transcript of WVE earnings conference call or presentation 2-Mar-20 1:00pm GMT [Yahoo! Finance News] 6.7%
8/29 Wave Life Sciences Ltd (NASDAQ: WVE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 6.7%
7/29 Wave Life Sciences Reports Second Quarter 2019 Financial Results and Provides Business Update 5.7%
10/19 Wave Life Sciences Ltd (NASDAQ: WVE) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.1%
5/24 Wave Life Sciences Ltd (NASDAQ: WVE) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 5.0%
TOP News Decliners
12/16
Wave Life Sciences Announces Discontinuation of Suvodirsen Development for Duchenne Muscular Dystrophy
-55.3%
12/30 Wave Life Sciences Announces Topline Data and Addition of Higher Dose Cohort in Ongoing Phase 1b/2a PRECISION-HD2 Trial in Huntington’s Disease -49.5%
12/16 Wave Life Sciences Ltd (NASDAQ: WVE) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -9.8%
2/20 Form 4 Wave Life Sciences Ltd. For: Feb 18 Filed by: Vargeese Chandra -8.5%
1/10 Form 8-K Wave Life Sciences Ltd. For: Jan 09 -8.4%
3/7 Wave Life Sciences Ltd (NASDAQ: WVE) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock. -6.5%
3/2 Q4/2019 12/31/2019 EPS -1.650 ZacksConsensus -1.480 ActVsEst (0.170) - Miss -6.0%
9/6 Wave Life Sciences to Host Analyst and Investor Research Day on October 7, 2019 -5.5%
5/20 Wave Life Sciences Ltd (NASDAQ: WVE) had its price target lowered by analysts at SunTrust Banks, Inc. to $39.00. They now have a "buy" rating on the stock. -4.9%
10/7 Form 8-K Wave Life Sciences Ltd. For: Oct 07 -4.0%
12/30 Wave Life Sciences Announces Topline Data and Addition of Higher Dose Cohort in Ongoing Phase 1b/2a PRECISION-HD2 Trial in Huntington’s Disease -49.5%
12/16 Wave Life Sciences Ltd (NASDAQ: WVE) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -9.8%
2/20 Form 4 Wave Life Sciences Ltd. For: Feb 18 Filed by: Vargeese Chandra -8.5%
1/10 Form 8-K Wave Life Sciences Ltd. For: Jan 09 -8.4%
3/7 Wave Life Sciences Ltd (NASDAQ: WVE) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock. -6.5%
3/2 Q4/2019 12/31/2019 EPS -1.650 ZacksConsensus -1.480 ActVsEst (0.170) - Miss -6.0%
9/6 Wave Life Sciences to Host Analyst and Investor Research Day on October 7, 2019 -5.5%
5/20 Wave Life Sciences Ltd (NASDAQ: WVE) had its price target lowered by analysts at SunTrust Banks, Inc. to $39.00. They now have a "buy" rating on the stock. -4.9%
10/7 Form 8-K Wave Life Sciences Ltd. For: Oct 07 -4.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: